ORCHIDPHAR

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on September 07, 2020.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on Jun 29, 2020.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on February 17, 2020.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 14, 2019.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on August 12, 2019.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on Jun 03, 2019.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on February 13, 2019.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on January 29, 2019.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 30, 2018.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on November 30, 2018.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on April 17, 2018.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on March 16, 2018.

Orchid Pharma Limited has informed the Exchange regarding Board meeting held on March 05, 2018.

Orchid Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on May 26, 2017.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Outcome of the Board Meeting held on July 14, 2014.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the press release with respect to the financial results for the period ended September 30,2013

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the press release in-connection with the financial results for the quarter ended June 30, 2013.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Outcome of Board Meeting of the Company held on April 17, 2013.

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board of Directors of the Company at their meeting held on January 07, 2012, inter-alia has approved a Scheme of Amalgamation ('the Scheme') for merger of company's wholly owned subsidiary viz. Orchid Research Laboratories Limited ('the transferor company') with Orchid under the provisions of Sections 391 to 394 of the Companies Act, 1956. The Appointed date of the Amalgamation is April 01, 2010 and the Scheme is subject to the approval of The Hon'ble High Court of Madras. The transferor company being a wholly owned

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the following has been considered at a meeting of the Board of Directors of the Company held on May 18, 2011 :- (1) Raising of long term resources; (2) Increase in Authorised Capital.

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange "that the following has been considered at a meeting of the Board of Directors of the Company held on Friday, January 19, 2007:- (a) Issue of Warrants - Issue of 5 million Warrants, convertible into Equity Share to the Promoter(s)/Promoter Group(s)/Relatives of Prmoters in accordance with the SEBI Guidelines for Preferential Issue in lieu of 3.56 million unsubscribed warrants as on date. (b) Extraordinary General Meeting - An Extraordinary General Meeting of the Company has been proposed to be held on Wednesday, February 14, 2007

Orchid Chemicals & Pharmaceuticals Ltd has informed the Exchange regarding the following, which has been considered at a meeting of the Board of Directors of Orchid Chemicals & Pharmaceuticals Limited, held on June 15, 2005:- a)Raising of Additional long term resources:- In order to meet the further financial outlay on Multi-therapeutic expansion and to reduce the interest burden, the Company proposes to raise long terms funds by way of issue of GDRs in the International Market of US$ 100 million, with additional 15% Green Shoe Option. b)Issue of Warrants:- Issue of 25 lakh Warrants, convertib